Literature DB >> 27426266

Analysis of antibody-drug conjugates by comprehensive on-line two-dimensional hydrophobic interaction chromatography x reversed phase liquid chromatography hyphenated to high resolution mass spectrometry. I - Optimization of separation conditions.

Morgan Sarrut1, Amélie Corgier1, Szabolcs Fekete2, Davy Guillarme2, David Lascoux3, Marie-Claire Janin-Bussat4, Alain Beck4, Sabine Heinisch5.   

Abstract

Antibody-drug-conjugates (ADCs) manufacturing leads to a mixture of species which needs to be characterized during development and for further quality control. The coupling of on-line HIC x RPLC to high resolution mass spectrometry can be considered as a very efficient analytical method, providing extensive information on ADC sample, within a reduced time scale. Our intention in this first paper is to present the approach used to rationally optimize the numerous conditions that can affect the quality of the 2D-separation. HIC and RPLC conditions were therefore optimized to prevent salt precipitation due to solvent mixing and to enhance sensitivity, while limiting the total analysis time. We demonstrated that adding salt in the sample solvent before HIC injection allows a significant peak shape improvement. The gradient profile was also carefully optimized in both dimensions, leading to a two-step gradient in HIC and bracketed gradient in RPLC. This study shows that on-line HIC x RPLC hyphenated to high resolution mass spectrometry is a useful method to obtain rapid and extensive structural information on the peaks observed in the first HIC dimension, thereby leading, in a single step requiring 75min, to the precise determination of the average drug-to-antibody ratio (DAR) by HIC as well as the knowledge of the drug load distribution for a particular DAR. The structural characterization of ADC fragments by RPLC-QTOF will be discussed in the second part of this two-part series.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ADC; Adcetris(®); Antibody-drug conjugate; Brentuximab vedotin; HICxRPLC-QTOF-MS; On-line comprehensive 2D-LC

Mesh:

Substances:

Year:  2016        PMID: 27426266     DOI: 10.1016/j.jchromb.2016.06.048

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  9 in total

Review 1.  Strategies and challenges for the next generation of antibody-drug conjugates.

Authors:  Alain Beck; Liliane Goetsch; Charles Dumontet; Nathalie Corvaïa
Journal:  Nat Rev Drug Discov       Date:  2017-03-17       Impact factor: 84.694

Review 2.  Challenges and new frontiers in analytical characterization of antibody-drug conjugates.

Authors:  Anil Wagh; Hangtian Song; Ming Zeng; Li Tao; Tapan K Das
Journal:  MAbs       Date:  2018-01-05       Impact factor: 5.857

Review 3.  Practical approaches for overcoming challenges in heightened characterization of antibody-drug conjugates with new methodologies and ultrahigh-resolution mass spectrometry.

Authors:  Olga V Friese; Jacquelynn N Smith; Paul W Brown; Jason C Rouse
Journal:  MAbs       Date:  2018-02-20       Impact factor: 5.857

Review 4.  Different Stationary Phase Selectivities and Morphologies for Intact Protein Separations.

Authors:  A Astefanei; I Dapic; M Camenzuli
Journal:  Chromatographia       Date:  2016-09-23       Impact factor: 2.044

5.  Influence of disulfide bond isoforms on drug conjugation sites in cysteine-linked IgG2 antibody-drug conjugates.

Authors:  Lily Liu-Shin; Adam Fung; Arun Malhotra; Gayathri Ratnaswamy
Journal:  MAbs       Date:  2018-03-06       Impact factor: 5.857

Review 6.  Current LC-MS-based strategies for characterization and quantification of antibody-drug conjugates.

Authors:  Xiaoyu Zhu; Shihan Huo; Chao Xue; Bo An; Jun Qu
Journal:  J Pharm Anal       Date:  2020-05-23

Review 7.  Optimizing separations in online comprehensive two-dimensional liquid chromatography.

Authors:  Bob W J Pirok; Andrea F G Gargano; Peter J Schoenmakers
Journal:  J Sep Sci       Date:  2017-11-23       Impact factor: 3.645

Review 8.  Recent applications of retention modelling in liquid chromatography.

Authors:  Mimi J den Uijl; Peter J Schoenmakers; Bob W J Pirok; Maarten R van Bommel
Journal:  J Sep Sci       Date:  2020-11-03       Impact factor: 3.645

Review 9.  Stepping forward in antibody-drug conjugate development.

Authors:  Yiming Jin; Megan A Schladetsch; Xueting Huang; Marcy J Balunas; Andrew J Wiemer
Journal:  Pharmacol Ther       Date:  2021-06-24       Impact factor: 12.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.